Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SIB-Norwegian Version, Validation and Reliability Study

This study has been completed.
Information provided by:
Sykehuset Innlandet HF Identifier:
First received: March 19, 2007
Last updated: July 2, 2007
Last verified: July 2007
The purpose of this study is to validate and to test interrater reliability for the Norwgian version of Severe Impairment Battery (SIB).

Condition Intervention
Diagnostic Tests, Routine
Behavioral: Diagnostic Screening

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Retrospective/Prospective
Official Title: Severe Impairment Study - Norwegian Version. A Validation and Reliability Study.

Resource links provided by NLM:

Further study details as provided by Sykehuset Innlandet HF:

Enrollment: 59
Study Start Date: February 2007
Study Completion Date: May 2007
Detailed Description:
The study will include 60 persons with mild to severe dementia. To test the validation of SIB, we will interview the included persons with Severe Impairment Battery (SIB) and compare the results with Clinical Dementia Rating (CDV)reported by their nurses. To test interrater reliability 30 of the included persons will be interviewed with SIB by two different raters, and the two raters results will be compared.

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Dementia, mild to severe.
  • Nursing Home resident

Exclusion Criteria:

  • No ability to write or read.
  • Physical handicapped, unable to use hands.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00449384

Sykehuset Innlandet HF - Sanderud
Ottestad, Oppland, Norway, 2312
Sponsors and Collaborators
Sykehuset Innlandet HF
Study Chair: Knut Engedal, PhD The Norwegian Centre for Dementia Research (NCDR), Norway
  More Information Identifier: NCT00449384     History of Changes
Other Study ID Numbers: F06002 
Study First Received: March 19, 2007
Last Updated: July 2, 2007
Health Authority: Norway: Norwegian Social Science Data Services
Norway:National Committee for Medical and Health Research Ethics

Keywords provided by Sykehuset Innlandet HF:
Severe Impairment Battery
Clinical Dementia Rating

Additional relevant MeSH terms:
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurocognitive Disorders
Mental Disorders processed this record on October 21, 2016